Helicobacter pylori infection and gastroduodenal diseases in Vietnam: A cross-sectional, hospital-based study

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Nguyen, Tung L ^a   Uchida, Tomohisa ^a   Tsukamoto, Yoshiyuki ^a   Trinh, Dung T ^b   Ta, Long ^b   Mai, Bang H ^b   Le, Song H ^b   Thai, Ky D ^b   Ho, Dung D ^c   Hoang, Hai H ^c   Matsuhisa, Takeshi ^d   Okimoto, Tadayoshi ^a   Kodama, Masaaki ^a   Murakami, Kazunari ^a   Fujioka, Toshio ^a   Yamaoka, Yoshio ^a   Moriyama, Masatsugu ^a  

^a OITA UNIVERSITY   (Japan)

^b 108 Hospital   (Viet Nam)

^c CHO RAY HOSPITAL   (Viet Nam)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VACA M1 PROTEIN; VIRULENCE FACTOR; BACTERIAL DNA; BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATROPHY; BACTERIUM CULTURE; CHRONIC GASTRITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; STOMACH CANCER; URINALYSIS; VIET NAM; CLINICAL TRIAL; COMPARATIVE STUDY; DUODENUM DISEASE; GASTROINTESTINAL ENDOSCOPY; GENETICS; HELICOBACTER PYLORI; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; SEX RATIO; STOMACH DISEASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DUODENAL DISEASES; ENDOSCOPY, GASTROINTESTINAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; STOMACH DISEASES; VIETNAM; YOUNG ADULT;

EID: 77957193994     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-114     Document Type: Article

References (25)

1. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002, 2:28-37. 10.1038/nrc703, 11902583.
2. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002, 347:1175-1186. 10.1056/NEJMra020542, 12374879.
3. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007, 117:60-69. 10.1172/JCI30111, 1716216, 17200707.
4. Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997, 112:92-99. 10.1016/S0016-5085(97)70223-3, 8978347.
5. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008, 135:91-99. 10.1053/j.gastro.2008.03.041, 18474244.
6. Fukuta K, Azuma T, Ito Y, Suto H, Keida Y, Wakabayashi H, Watanabe A, Kuriyama M. Clinical relevance of cagE gene from Helicobacter pylori strains in Japan. Dig Dis Sci 2002, 47:667-674. 10.1023/A:1017949026509, 11911357.
7. Oleastro M, Cordeiro R, Ferrand J, Nunes B, Lehours P, Carvalho-Oliveira I, Mendes AI, Penque D, Monteiro L, Megraud F, et al. Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis 2008, 198:1379-1387. 10.1086/592166, 18811585.
8. Oleastro M, Cordeiro R, Menard A, Yamaoka Y, Queiroz D, Megraud F, Monteiro L. Allelic diversity and phylogeny of homB, a novel co-virulence marker of Helicobacter pylori. BMC Microbiol 2009, 9:248. 10.1186/1471-2180-9-248, 2795765, 19954539.
9. Peek RM, Thompson SA, Donahue JP, Tham KT, Atherton JC, Blaser MJ, Miller GG. Adherence to gastric epithelial cells induces expression of a Helicobacter pylori gene, iceA, that is associated with clinical outcome. Proc Assoc Am Physicians 1998, 110:531-544.
10. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY. Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 2002, 123:414-424. 10.1053/gast.2002.34781, 12145793.
11. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY. Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 2006, 55:775-781. 10.1136/gut.2005.083014, 1856239, 16322107.
12. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006, 118:3030-3044. 10.1002/ijc.21731, 16404738.
13. Ferlay JBF, Pisani P, et al. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Version 2.0.IARC CancerBase no 5. 2004, Lyon: IARC Press., http://www-dep.iarc.fr/
14. Nguyen LT, Uchida T, Murakami K, Fujioka T, Moriyama M. Helicobacter pylori virulence and the diversity of gastric cancer in Asia. J Med Microbiol 2008, 57:1445-1453. 10.1099/jmm.0.2008/003160-0, 19018013.
15. Yamaoka Y, Kato M, Asaka M. Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 2008, 47:1077-1083. 10.2169/internalmedicine.47.0975, 18552463.
16. Nguyen LT, Uchida T, Kuroda A, Tsukamoto Y, Trinh TD, Ta L, Mai HB, Ho DQ, Hoang HH, Vilaichone RK, et al. Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping. Clin Vaccine Immunol 2009, 16:1687-1692. 10.1128/CVI.00200-09, 2772380, 19776193.
17. Imagawa S, Yoshihara M, Ito M, Yoshida S, Wada Y, Tatsugami M, Takamura A, Tanaka S, Haruma K, Chayama K. Evaluation of gastric cancer risk using topography of histological gastritis: a large-scaled cross-sectional study. Dig Dis Sci 2008, 53:1818-1823. 10.1007/s10620-007-0077-x, 17999184.
18. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345:784-789. 10.1056/NEJMoa001999, 11556297.
19. Atherton JC, Cover TL, Twells RJ, Morales MR, Hawkey CJ, Blaser MJ. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol 1999, 37:2979-2982. 85427, 10449485.
20. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999, 96:12778-12783. 10.1073/pnas.96.22.12778, 23096, 10535999.
21. Ikenoue T, Maeda S, Ogura K, Akanuma M, Mitsuno Y, Imai Y, Yoshida H, Shiratori Y, Omata M. Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 2001, 8:181-186. 96031, 11139216.
22. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999, 37:2274-2279. 85136, 10364597.
23. Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol 2006, 41:1-9. 10.1007/s00535-005-1743-4, 16501851.
24. Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett 2002, 517:180-184. 10.1016/S0014-5793(02)02617-0, 12062433.
25. Oleastro M, Cordeiro R, Yamaoka Y, Queiroz D, Megraud F, Monteiro L, Menard A. Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog 2009, 1:12. 10.1186/1757-4749-1-12, 2706848, 19545429.